Innate Pharma S.A. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| EXCHANGE TRADED CONCEPTS, LLC | 01/21/2025 | 77,350 | $143,098 | 0.00% | 0.10% |
| UBS GROUP AG | 02/14/2025 | 3,510 | $6,459 | -58.25% | 0.00% |
| RHUMBLINE ADVISERS | 01/30/2025 | 675 | $1,248 | 229.27% | 0.00% |
| NATIONAL BANK OF CANADA /FI/ | 02/12/2025 | 450 | $828 | 100.00% | 0.00% |
| BARCLAYS PLC | 02/13/2025 | 307 | $1,000 | 0.00% | 0.00% |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 02/06/2025 | 200 | $368 | 0.00% | 0.00% |
| OPTIVER HOLDING B.V. | 02/14/2025 | 101 | $187 | -99.88% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Innate Pharma S.A. institutional Ownership - FAQ's
During the previous two years, 10 institutional investors and hedge funds held shares of Innate Pharma S.A.. The most heavily invested institutionals were:
EXCHANGE TRADED CONCEPTS, LLC: 77,350
UBS Group AG: 3,510
RHUMBLINE ADVISERS: 675
NATIONAL BANK OF CANADA /FI/: 450
BARCLAYS PLC: 307
Steward Partners Investment Advisory, LLC: 200
0.17% of Innate Pharma S.A. stock is owned by institutional investors.
Institutional investors have bought a total of 147,399 shares in the last 24 months. This purchase volume represents approximately $277,110 in transactions.